{"text": "TITLE:\n      Safety and Efficacy of BOTOX\u00ae (Botulinum Toxin Type A) in Korea\nSUMMARY:\n      This post marketing surveillance study in Korea will evaluate the safety and efficacy of\n      BOTOX (botulinum toxin Type A) in patients who receive treatment according to standard of\n      care for primary axillary hyperhidrosis, focal spasticity or moderate to severe glabellar\n      lines in clinical practice.\nELIGIBILITY CRITERIA:\n      Inclusion Criteria:\n          -  Patients treated with BOTOX\u00ae (botulinum toxin Type A) as prescribed according to\n             standard of care in clinical practice for primary axillary hyperhidrosis, focal\n             spasticity or moderate to severe glabellar lines.\n        Exclusion Criteria:\n", "cuis": "C0006050 C0006051 C0700702 C1552616 C1706244 C0733511 C2350596 C0150350 C0260572 C0947630 C0220825 C0006055 C0006050 C0006051 C2719430 C0382979 C2719424 C2719767 C0087111 C3887704 C0376495 C1533734 C0746919 C0814472 C3647788 C0700702 C1552651 C0038137 C2828392 C3272550 C0020458 C2678429 C0026838 C0004454 C0024947 C0580931 C0222694 C1306232 C1547226 C4049705 C4049706 C0237607 C3245512 C3272565 C0243161 C0013893 C0243161 C0006055 C0006050 C0006051 C2719430 C0382979 C2719424 C2719767 C0278329 C0700702 C1552651 C1550655 C1578485 C1578486 C2360836 C2360838 C2360840 C0332155 C2936643 C0020458 C2678429 C0237607 C3245512 C0004454 C0024947 C3272565 C0026838 C0222694 C1306232 C1547226 C4049705 C4049706 C0243161 ", "concepts": "Botulinum Toxins, Type A, Botulinum Toxin Type B, botox summary, summary surveillance, Biosurveillances, skn surveillance, Iud surveillance, study, Evaluate botulinum toxin, botulinum toxin type, botulinum b toxin, botulinum B toxin, botulinum F toxin, abobotulinum toxin A, onabotulinum toxin A, Treatment, treatment, Retreatment, Treatment, no treatment, co-treatment, maltreatment, botox, Type, standards, Standard, Standard hyperhidrosis, No hyperhidrosis, spasticity, axillary, Maxillary, care, glabella, severed, Moderate, Moderate, Moderate practices, practice, Clinical criteria, Eligibility Criteria botulinum toxin, botulinum toxin type, botulinum b toxin, botulinum B toxin, botulinum F toxin, abobotulinum toxin A, onabotulinum toxin A, prescribed, botox, Type, Patient, Patient, Patient, Patient, Patient, Patient, untreated standard of care, hyperhidrosis, No hyperhidrosis, practices, practice, axillary, Maxillary, Clinical spasticity, glabella, severed, Moderate, Moderate, Moderate Criteria "}
